Insights into the cellular events preceding RANKL upregulation in RA CD4+ T cells or Th17 cells remain unclear and establishing this cellular pathway is critical for exploiting the cellular or molecular targets contributing to increased bone erosion in RA with respect to pTh17s. Here, CD4 is linked to rheumatoid arthritis.